Delve into Your DNA: Uncover Cancer Risks with Vitall’s Polygenic Risk Scoring Tests
In the evolving landscape of preventive healthcare, understanding one's genetic predisposition towards certain diseases is becoming increasingly important. Polygenic Risk Scoring (PRS) is a concept that has emerged at the forefront of cancer risk assessment, offering a detailed understanding of how our genes could potentially influence our health outcomes.
Vitall’s at-home saliva tests, designed for both men and women, utilise this robust science to assess predisposed risks for prevalent cancers. Let’s delve deeper into what Polygenic Risk Scoring entails, its advantages, and how it fits with Vitall’s testing service to offer a proactive approach towards cancer prevention.
Unpacking Polygenic Risk Scoring
Polygenic Risk Scoring is a method that aggregates the effect of many genetic variants across your DNA to compute a cumulative risk score for certain diseases. This scoring system identifies numerous Single Nucleotide Polymorphisms (SNPs) associated with increased risks for diseases like cancer, cardiovascular disease, diabetes, and Alzheimer's. By leveraging a Polygenic Score Algorithm, PRS provides a personalised glimpse into your genetic landscape, uncovering how your genes might influence your risk for these conditions.
Advantages of Polygenic Risk Scoring
-
Personalised Risk Assessment:
- Beyond general statistics, a Polygenic Risk Assessment offers a more personalised insight into your predisposition towards certain health conditions, empowering you with the knowledge to make informed healthcare decisions.
-
Early Detection and Proactive Prevention:
- Unveiling your genetic predispositions early can guide potential lifestyle adjustments and accelerated screenings, crucial steps towards early detection and proactive prevention of diseases.
-
Accessible and Affordable Testing:
- With the advent of services like Vitall, Genetic Risk Scoring has become more accessible. The convenience of at-home testing removes the need for clinic visits, making it a cost-effective alternative.
How Polygenic Risk Scoring Works:
-
Collection of Genetic Data:
- Initially, a sample of DNA is collected, typically through a saliva sample or a blood draw.
-
Genotyping:
- The DNA sample is then genotyped to identify the specific alleles present at multiple genetic loci across the genome.
-
Identification of SNPs:
- Single Nucleotide Polymorphisms (SNPs) are identified. SNPs are variations at a single position in a DNA sequence among individuals.
-
Scoring:
- A score is calculated based on the presence of certain SNPs that are associated with the disease in question. Each SNP contributes to the score based on its individual effect size which is often determined from previous genetic studies.
-
Risk Assessment:
- The cumulative score from all the SNPs is used to estimate the individual’s genetic risk of developing the disease in the next ten years.
Post-Analysis:
Once the analysis is complete, the polygenic risk score can provide insights into an individual's risk of developing certain diseases. This information can be used to:
-
Inform Lifestyle Changes:
- Individuals can use this information to make lifestyle changes that may mitigate their risks.
-
Guide Screening and Prevention:
- Healthcare providers can use the PRS to tailor screening programs and preventive measures for individuals.
-
Research:
- PRS is also a valuable tool in research for understanding the genetic architecture of complex diseases.
Applying PRS to Vitall’s Multi-Cancer Risk Tests
Vitall's at-home saliva tests are grounded in cutting-edge Polygenic Risk Analysis. By evaluating specific genetic variants supported by Everything Genetic’s clinical insights, these tests provide a comprehensive assessment of your risk for prevalent cancers.
Women’s Multi-Cancer Risk Test
This test is tailored for women, assessing the risk for breast, colorectal, and melanoma cancers. Utilising a Genome-wide Polygenic Scoring approach, it provides an advanced understanding of your risk over the next decade, regardless of your family history. The objective here is to equip you with knowledge, enabling proactive screening and informed health and lifestyle choices.
Men are faced with the risk of prostate, colorectal, and melanoma cancers. This test employs a state-of-the-art Polygenic Risk Score Algorithm analysing 240 specific genetic variants (SNPs) to gauge your predisposition. The insight garnered from this test serves as a compass for lifestyle and dietary changes aimed at mitigating potential risks.
We also offer individual tests for breast, colorectal, melanoma and prostate risks scoring!
Embracing the Benefits of Polygenic Risk Scoring
Understanding Polygenic Risk Scores is a step towards proactive health management. Vitall’s Multi-Cancer Risk Tests, offer a convenient, affordable pathway to assess your genetic risk right from the comfort of your home. The ease of testing paired with robust clinical support from Everything Genetic sets a new standard in the UK Polygenic Risk Scoring landscape.
As the conversation around preventive healthcare evolves, so does the opportunity to engage with services like Vitall’s PRS Testing Service. It’s not just about unveiling what your genes may hold, but about embarking on a health journey with a clear roadmap.
Get Yourself Tested With Vitall's Home Test Kits
Article Reviewed By
Dr. Laura Roberts |Clinical Content Creator
More Articles in These Categories
Similar Articles
View all articles ›Revolutionary Blood Test Offers Hope for Early Identification of Prevalent Life-Threatening Cancers
25% of Cancer Patients Face Over Two-Month Delays to Consult Specialists
Revolutionary Blood Test Promises Early Cancer Detection for Li-Fraumeni Syndrome Patients
Team of Scientists Score $2.4 Million Investment to Confirm Revolutionary Blood Test for Early Breast Cancer Detection
Groundbreaking Funding from PanKind Paves the Way for Pancreatic Cancer's First Early Detection Blood Test
Revolutionary DNA Test: A New Beacon of Hope in Early Detection of 18 Types of Cancer, Claim Scientists.
Revolutionary Blood Test Holds Potential to Spot Early-Stage Cancers with Remarkable Precision
New Research Questions the Need for Rectal Exams in Prostate Cancer Detection
Revolutionary Blood Test for Brain Cancer Could Boost Survival Rates, Experts Suggest
When Your Physician Recommends a Medical Scan: Understanding the Advantages and Necessary Precautions
References & Citations For Delve into Your DNA: Uncover Cancer Risks with Vitall’s Polygenic Risk Scoring Tests
-
Khera, A. V., Chaffin, M., Aragam, K. G., Haas, M. E., Roselli, C., Choi, S. H., ... & Natarajan, P. (2018). Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nature Genetics, 50(9), 1219-1224. Link to Paper
-
Torkamani, A., Wineinger, N. E., & Topol, E. J. (2018). The personal and clinical utility of polygenic risk scores. Nature Reviews Genetics, 19(9), 581-590. Link to Paper
-
Dudbridge, F. (2013). Power and Predictive Accuracy of Polygenic Risk Scores. PLoS Genetics, 9(3), e1003348. Link to Paper
-
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019). Clinical use of current polygenic risk scores may exacerbate health disparities. Nature Genetics, 51(4), 584-591. Link to Paper
-
Mavaddat, N., Michailidou, K., Dennis, J., Lush, M., Fachal, L., Lee, A., ... & Dunning, A. M. (2019). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics, 104(1), 21-34. Link to Paper
These papers delve into the methodology, application, and implications of Polygenic Risk Scoring.
All Testing Is Conducted In UKAS Accredited Laboratories.
© 2026 Healthy Human Labs LTD, 71 - 75 Shelton Street, Covent Garden, London, WC2H 9JQ.

